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Although hypertension is a prevalent condition among the elderly, little is known with respect to the influence of 
hypertension on oral health and function. Therefore a study was conducted that compared stimulated parotid salivary flow 
rates in elderly persons (65 years and older) from two diverse populations who are normotensive, mild, and severe 
hypertensive. The normotensive group consisted of 45 healthy subjects with systolic blood pressures of less than 140 mm Hg 
and diastolic pressures less than 90 mm Hg. The mildly hypertensive group consisted of 14 otherwise healthy subjects with 
either systolic pressures greater than 140 mm Hg or diastolic pressures greater than 90 mm Hg. The severely hypertensive 
group consisted of 10 otherwise healthy subjects with either systolic pressures greater than 180 mm Hg and/or diastolic 
pressures greater than 100 mm Hg. All three groups were not taking any prescription or nonprescription medications. Samples 
of 2% citrate-stimulated parotid saliva were collected from each subject. The results showed no significant differences in 
stimulated parotid flow between normotensive, mildly hypertensive, and severely hypertensive subjects. These results suggest 
that hypertension per se has no influence on stimulated parotid salivary gland flow rates in otherwise healthy, elderly 
unmedicated white and African-American persons. (ORAL SURC ORAL MED ORAL PATHOL 1994;77z615-9) 
The production of saliva by the major and minor sal- 
ivary glands is essential for the maintenance and pro- 
tection of the hard and soft tissues of the oral cavity 
and the inhibition of serious systemic pathogens.’ In 
addition, saliva has an important functional role in 
speech, swallowing, and mastication.2 
Dryness of the mouth, xerostomia, is usually a 
common complaint of the elderly especially among 
persons who are hypertensive.3 Several investigators 
have attributed this symptom to the side effects 
resulting from the use of antihypertensive medica- 
tions.4v 5 Hydrochlorothiazide, for example, has been 
shown to decrease stimulated whole saliva and stim- 
ulated parotid gland saliva in patients who take med- 
ication for the treatment of hypertension.4* G* 
Other reports concern the effects of antihyperten- 
sive medications on salivary flow; however, there is 
little information concerning salivary gland function 
in hypertensive persons before treatment with anti- 
hypertensive medications. Ben-Aryeh et a1.9 reported 
lower unstimulated whole saliva flow rates in 10 pa- 
tients with essential hypertension when compared 
with age and gender matched normotensive controls. 
Conversely, in a racially mixed population, Nieder- 
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meier et al.,” found no differences in unstimulated 
and stimulated whole salivary flow rates in persons 
with hypertension when compared with a control 
group with normal blood pressure. Both studies used 
whole saliva in their investigations. However, no 
information is available on the influence of elevated 
blood pressure on major salivary gland flow rates. 
The purpose of this study was to investigate the ef- 
fects of hypertension on stimulated parotid flow in two 
different elderly populations, one white and the other 
African-American. 
MATERIAL AND METHODS 
Populations 
Baltimore Longitudinal Study of Aging. The sub- 
jects participating in this study were volunteer par- 
ticipants in the oral physiology component” of the 
Baltimore Longitudinal Study of Aging (BLSA).12 
All were community dwelling, ambulatory, elderly 
(65 years and older) whites of middle socioeconomic 
class seen by one investigator (J.A.S.). Participants 
were examined by a physician, and diagnoses of hy- 
pertension were based on clinical findings and medi- 
cal histories.13 The normotensive or the hypertensive 
groups had never used any antihypertensive medica- 
tions. In addition, they were not taking any prescrip- 
tion or nonprescription medications at the time of 
evaluation. 
Washington Village Medical Center. The subjects 
participating in this study from the Washington Vil- 
lage Medical Center (WVMC) were African-Amer- 
icans residing in the southwest section of Baltimore 
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Table I. Numbers of subjects, mean blood pressures, 
and salivary flow rates for study population groups ~- .-~ ~_ 
1 n ,;;i$ Groups 
BLSA* 31 120 
normotensives 
BLSA 14 139 
hypertensives 
(mild) 
WVMCt I5 129 
normotensives 
WVMC 10 167 
hypertensives 
(severe) 



















*Baltimore Longitudinal Study on Aging 
iwashington Village Medical Center. 
City, Md. All were ambulatory, geriatric patients (65 
years old and older) who were seeking routine med- 
ical and dental care at the WVMC, were of a low so- 
cioeconomic class, and were seen by one investigator 
(C.F.S.). Detailed demographic and social charac- 
teristics have been reported previously.14 
The hypertensive persons from the WVMC who 
were used in this study were asymptomatic persons 
who were found to have undiagnosed hypertension as 
a result of routine hypertension screenings at the 
dental clinic. Stimulated parotid flow rates were de- 
termined before the persons were to initiate their an- 
tihypertension therapy. The participants from the 
WVMC had never taken antihypertensive medica- 
tions and were not taking any prescription or nonpre- 
scription medications at the time of evaluation. 
Blood pressure determinations 
Blood pressures were taken between 8 AM and 12 
M. with a Baumanometer on the right arm with the 
patient in a sitting position. The blood pressure values 
were determined according to the criteria established 
in the 1993 edition of the Fifth Report of the Joint 
National Committee on Detection, Evaluation, and 
Treatment of High Blood Pressure.“15 The categories 
of blood pressure were also established according to 
the classifications published in this volume.15 The 
classifications are: normotensive, high normal nor- 
motensive, and hypertensive.t5 
Normotension was defined as systolic blood pres- 
sure less than 130 mm Hg and diastolic pressure less 
than 90 mm Hg. High normal hypertensive persons 
were those with a systolic pressure of 130 to 139 mm 
Hg and diastolic pressure less than 90 mm Hg. The 
high normotensive were also included in the nor- 
motensive group in this study. 
Hypertension was classitied into four subcatego- 
ries: mild hypertension, moderate hypertension, se- 
vere hypertension, and very severe hypertension. 
Mild hypertension was defined as a systolic blood 
pressure greater than 140 mm Hg but less than 159 
mm Hg and diastolic pressure greater than 90 mm Hg 
but less than 100 mm Hg. Moderate hypertension was 
defined as systolic pressure greater than 160 mm Hg 
but less than 179 mm Hg and diastolic pressure 
greater than 100 mm Hg but less than 109 mm Hg. 
Severe hypertension was defined as systolic pressure 
greater than 180 mm Hg but less than 209 mm Hg 
and diastolic pressure greater than 110 mm Hg but 
less than 119 mm Hg. Very severe hypertension was 
defined as systolic pressure greater than 210 mm Hg 
and diastolic pressure greater than 120 mm Hg. 
When the systolic and diastolic pressures were in dif- 
ferent categories, the higher category was used to 
classify the person’s blood pressure status. 
The methods (time of day, subject position, and 
type of sphygmomanometer) for blood pressure de- 
termination were common to both facilities.ls In ad- 
dition, hypertension in both populations was diag- 
nosed as essential hypertension with no “target organ 
(diabetes, left ventricular hypertrophy, etc.)” involve- 
ment. 
Collection of saliva 
Saliva was collected from one parotid gland be- 
tween the hours of 8 AM to 12 M to minimize the ef- 
fect of circadian variances.t6 The Carlson-Crittenden 
Cup was used to collect saliva.“. ‘* Subjects did not 
eat, drink, or perform oral hygiene at least 2 hours 
before collection. The Stenson’s duct was isolated, 
and the cup positioned over the orifice. Saliva was 
stimulated for a 2-minute equilibrium period followed 
by a 2-minute collection period. A 2% citric acid so- 
lution was applied to the dorsum of the tongue every 
30 seconds during the 2-minute equilibrium and 
2-minute collection periods. Samples were collected 
in preweighed plastic tubes, and salivary output was 
determined gravimetrically assuming a specific grav- 
ity of 1.0 gms/cm3. 
Statistical analysis 
The data analysis was performed on an IBM 370 
mainframe computer using the SAS Statistical Soft- 
ware Package. l9 Descriptive analyses were performed 
on both groups within each separate population. A 
PROC GLM for unbalanced analysis of variance was 
used to compare mean levels of stimulated parotid 
ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY 
Volume 77, Number 6 
Streckfus et al. 617 
NORMOTENSIVE MILDLY HYPERTENSIVE SEVERELY HYPERTENSIVE 
LEVELS OF BLOOD PRESSURE 
m SPFR mL/Min. 
F-ratio 0.70, p= not significant 
Fig. 1. Stimulated parotid flow rates according to blood pressure status. 
Table II. Analysis of variance of population, hypertension status, and hypertension levels for differences in 
stimulated parotid flow rates 
Source Sum of squares df 
Overall model 0.37 3 
Population 0.32 1 
Hypertension 0.04 1 
Population X Hypertension 0.03 1 










flow rates (SPFR) in milliliters per minute among the 
four groups of subjects. The models contained two 
classification variables as main effects: population or 
site (BLSA versus WVMC representing race) and 
hypertension status (normotensive versus hyperten- 
sive). Because of the small number of women in some 
of the groups (severe hypertensives), gender differ- 
ences as a variable were not analyzed. However, in 
previous studies at the BLSA”? 17y 21, 22 and at 
WVMC7 no gender differences were found in SPFR 
among either populations. 
The data sets were then combined and analysis of 
variance (PROC GLM) was used to detect differ- 
ences across three levels of hypertension status, nor- 
motensive, mildly hypertensive, and severely hyper- 
tensive.19 The level of significance referenced for 
these analyses was p < 0.05. 
RESULTS 
The mean systolic and diastolic blood pressures 
that placed a person into each blood pressure group 
are given in Table I. Mean normotensive systolic 
pressures for the BLSA, WVMC, and the combina- 
tion of both sites were 120,129, and 125, respectively. 
The mean normotensive diastolic pressures were 67 
(BLSA), 86 (WVMC), and 76 (combined data). 
Systolic pressures for the hypertensive group were 139 
for the BLSA and 167 for WVMC. Diastolic pres- 
sures for the hypertensive group were 93 for BLSA 
and 112 for WVMC. In addition, no moderate, severe, 
or very severe hypertensive persons were found in the 
BLSA population, and no mildly or very severe 
hypertensive persons were found in the WVMC pop- 
ulation. 
Mean SPFR ranged from 0.59 to 0.69 ml/min for 
the normotensive subjects (BLSA and WVMC, re- 
spectively) whereas the hypertensive SPFR were 0.49 
to 0.68 ml/min. 
An analysis of variance was performed to deter- 
mine statistical differences between populations 
(BLSA, WVMC) and blood pressures (normotensive, 
hypertensive) with respect to SPFR. The results of the 
618 Streckfus et al. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY 
June 1994 
analysis of variance showed no significant main effect 
or interaction with respect to site or hypertension on 
SPFR (Table II). 
Because there were no significant differences in 
SPFR between the BLSA and WVMC, the nor- 
motensive groups in the two sites were combined and 
an analysis of variance was performed on three levels 
of blood pressure (Fig. 1). The results of the analysis 
also showed no significant differences between groups 
(Table II). 
DISCUSSION 
The results of this investigation showed no signif- 
icant differences in SPFR between normotensive and 
hypertensive persons. These results parallel the previ- 
ous study by Niedermeier et al.” that indicated no 
differences in unstimulated and stimulated whole sa- 
liva flow rates between normotensive and hyperten- 
sive white and African-American persons. In addi- 
tion, there have been individual case reports that ap- 
pear to indicate that SPFR remain the same in both 
normotensive and hypertensive conditions and that 
SPFR are not altered until a patient is placed on 
medication.20 
A weakness of this study is that it is based solely on 
cross-sectional analysis, and it has been suggested 
that it is difficult to determine normal salivary gland 
flow rates without longitudinal observations.** In ad- 
dition, normal salivary performance for one person 
may not necessarily be the same for another under 
similar medical conditions.** However, the values for 
SPFR among hypertensive persons do coincide with 
the range of normal values reported by Ship et a1.22 
Studies that involve untreated hypertensive persons 
are difficult to implement because of the life-threat- 
ening nature of the untreated disease. As a conse- 
quence, investigations that demonstrate the iatro- 
genie effects of antihypertensive medications on sal- 
ivary function usually consist of medicated persons 
and nonmedicated controls. Therefore it has been 
difficult to assess the effects of the disease in its un- 
controlled state on salivary function.*? l4 Despite the 
small number of subjects in this investigation, the re- 
sults suggest that hypertension per se does not cause 
a diminution of stimulated parotid flow in white and 
African-American persons. Previous reports of sali- 
vary gland dysfunction and xerostomia in hyperten- 
sives may more likely be due to specific medications 
used in the treatment of elevated blood pressure. 
By the year 2020, the elderly (65 years and older) 
will comprise nearly 22.3% of the total population in 
the United States.23l 24 Because hypertension is one of 
the most prevalent diseases in the elderly15 and sali- 
vary gland function is essential for the maintenance 
of oral health,’ more research is needed concerning 
the effects of hypertension and its treatment on sali- 
vary physiology. This is especially true in African- 
American populations where hypertension is more 
prevalent. 25 Studies with larger sample sizes are nec- 
essary to further examine the relationships between 
salivary function and hypertension. In addition, lon- 
gitudinal studies are necessary to fully assess the se- 
quelae of antihypertensive medications on salivary 
function. It is to be hoped that medical conditions and 
treatments, for example, medications, can be identi- 
fied that have deleterious consequences to oral health 
and appropriate preventive and treatment protocols 
instituted to ensure the maintenance of oral functions 
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